Page 138 - Read Online

Page 10 of 11 Nakamura et al. J Cancer Metastasis Treat 2018;4:32 I http://dx.doi.org/10.20517/2394-4722.2017.78

13.
24. Resel Folkersma L, Olivier Gómez C, San José Manso L, Veganzones de Castro S, Galante Romo I, Vidaurreta Lázaro M, de la Orden GV,
Arroyo Fernández M, Díaz Rubio E, Silmi Moyano A, Maestro de Las Casas MA. Immunomagnetic quantification of circulating tumoral
cells in patients with prostate cancer: clinical and pathological correlation. Arch Esp Urol 2010;63:23-31.
25. Andreopoulou E, Yang LY, Rangel KM, Reuben JM, Hsu L, Krishnamurthy S, Valero V, Fritsche HA, Cristofanilli M. Comparison of assay
methods for detection of circulating tumor cells in metastatic breast cancer: AdnaGen AdnaTest BreastCancer Select/Detect versus Veridex
CellSearch system. Int J Cancer 2012;130:1590-7.
26. Nagrath S, Sequist LV, Maheswaran S, Bell DW, Irimia D, Ulkus L, Smith MR, Kwak EL, Digumarthy S, Muzikansky A, Ryan P, Balis
UJ, Tompkins RG, Haber DA, Toner M. Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature
2007;450:1235-9.
27. Vona G, Sabile A, Louha M, Sitruk V, Romana S, Schütze K, Capron F, Franco D, Pazzagli M, Vekemans M, Lacour B, Bréchot C,
Paterlini-Bréchot P. Isolation by size of epithelial tumor cells: a new method for the immunomorphological and molecular characterization
of circulatingtumor cells. Am J Pathol 2000;156:57-63.
28. Rosenberg R, Gertler R, Friederichs J, Fuehrer K, Dahm M, Phelps R, Thorban S, Nekarda H, Siewert JR. Comparison of two density
gradient centrifugation systems for the enrichment of disseminated tumor cells in blood. Cytometry 2002;49:150-8.
29. Nedosekin DA, Juratli MA, Sarimollaoglu M, Moore CL, Rusch NJ, Smeltzer MS, Zharov VP, Galanzha EI. Photoacoustic and
photothermal detection of circulating tumor cells, bacteria and nanoparticles in cerebrospinal fluid in vivo and ex vivo. J Biophotonics
2013;6:523-33.
30. Arnold LW, Lannigan J. Practical issues in high-speed cell sorting. Curr Protoc Cytom 2010;Chapter 1:Unit 1.24.1-30.
31. Krivacic RT, Ladanyi A, Curry DN, Hsieh HB, Kuhn P, Bergsrud DE, Kepros JF, Barbera T, Ho MY, Chen LB, Lerner RA, Bruce RH. A
rare-cell detector for cancer. Proc Natl Acad Sci U S A 2004;101:10501-4.
32. Ntouroupi TG, Ntouroupi TG, Ashraf SQ, McGregor SB, Turney BW, Seppo A, Kim Y, Wang X, Kilpatrick MW, Tsipouras P, Tafas T,
Bodmer WF. Detection of circulating tumour cells in peripheral blood with an automated scanning fluorescence microscope. Br J Cancer
2008;99:789-95.
33. Smith BM, Slade MJ, English J, Graham H, Lüchtenborg M, Sinnett HD, Cross NC, Coombes RC. Response of circulating tumor cells to
systemic therapy in patients with metastatic breast cancer: comparison of quantitative polymerase chain reaction and immunocytochemical
techniques. J Clin Oncol 2000;18:1432-9.
34. Kowalewska M, Chechlińska M, Markowicz S, Kober P, Nowak R. The relevance of RT-PCR detection of disseminated tumour cells is
hampered by the expression of markers regarded as tumour-specific in activated lymphocytes. Eur J Cancer 2006;42:2671-4.
35. Alix-Panabières C, Vendrell JP, Pellé O, Rebillard X, Riethdorf S, Müller V, Fabbro M, Pantel K. Detection and characterization of putative
metastatic precursor cells in cancer patients. Clin Chem 2007;53:537-9.
36. Alix-Panabières C, Vendrell JP, Slijper M, Pellé O, Barbotte E, Mercier G, Jacot W, Fabbro M, Pantel K. Full-length cytokeratin-19 is
released by human tumor cells: a potential role in metastatic progression of breast cancer. Breast Cancer Res 2009;11:R39.
37. Wang S, Zheng G, Cheng B, Chen F, Wang Z, Chen Y, Wang Y, Xiong B. Circulating tumor cells (CTCs) detected by RT-PCR and its
prognostic role in gastric cancer: a meta-analysis of published literature. PLoS One 2014;9:e99259.
38. Zou K, Yang S, Zheng L, Wang S, Xiong B. Prognostic role of the circulating tumor cells detected by cytological methods in gastric cancer:
a meta-analysis. Biomed Res Int 2016;2016:2765464.
39. Huang X, Gao P, Sun J, Chen X, Song Y, Zhao J, Xu H, Wang Z. Clinicopathological and prognostic significance of circulating tumor cells
in patients with gastric cancer: a meta-analysis. Int J Cancer 2015;136:21-33.
40. Kang HM, Kim GH, Jeon HK, Kim DH, Jeon TY, Park DY, Jeong H, Chun WJ, Kim MH, Park J, Lim M, Kim TH, Cho YK. Circulating
tumor cells detected by lab-on-a-disc: role in early diagnosis of gastric cancer. PLoS One 2017;12:e0180251.
41. Li Y, Gong J, Zhang Q, Lu Z, Gao J, Li Y, Cao Y, Shen L. Dynamic monitoring of circulating tumour cells to evaluate therapeutic efficacy
in advanced gastric cancer. Br J Cancer 2016;114:138-45.
42. Shimazu K, Fukuda K, Yoshida T, Inoue M, Shibata H. High circulating tumor cell concentrations in a specific subtype of gastric cancer
with diffuse bone metastasis at diagnosis. World J Gastroenterol 2016;22:6083-8.
43. Gumusay O, Benekli M, Ekinci O, Baykara M, Ozet A, Coskun U, Demirci U, Uner A, Dursun A, Atak EY, Buyukberber S. Discordances
in HER2 status between primary gastric cancer and corresponding metastatic sites. Jpn J Clin Oncol 2015;45:416-21.
44. Iwatsuki M, Toyoshima K, Watanabe M, Hayashi N, Ishimoto T, Eto K, Iwagami S, Baba Y, Yoshida N, Hayashi A, Ohta Y, Baba H.
Frequency of HER2 expression of circulating tumour cells in patients with metastatic or recurrent gastrointestinal cancer. Br J Cancer
2013;109:2829-32.
45. Mishima Y, Matsusaka S, Chin K, Mikuniya M, Minowa S, Takayama T, Shibata H, Kuniyoshi R, Ogura M, Terui Y, Mizunuma N, Hatake K.
Detection of HER2 amplification in circulating tumor cells of HER2-negative gastric cancer patients. Target Oncol 2017;12:341-51.
46. Burrell RA, McGranahan N, Bartek J, Swanton C. The causes and consequences of genetic heterogeneity in cancer evolution. Nature
2013;501:338-45.
47. Scher HI, Graf RP, Schreiber NA, McLaughlin B, Jendrisak A, Wang Y, Lee J, Greene S, Krupa R, Lu D, Bamford P, Louw JE, Dugan L,
Vargas HA, Fleisher M, Landers M, Heller G, Dittamore R. Phenotypic heterogeneity of circulating tumor cells informs clinical decisions
between AR signaling inhibitors and taxanes in metastatic prostate cancer. Cancer Res 2017;77:5687-98.
48. Alix-Panabières C, Pantel K. Characterization of single circulating tumor cells. FEBS Lett 2017;591:2241-50.
49. Mohme M, Riethdorf S, Pantel K. Circulating and disseminated tumour cells - mechanisms of immune surveillance and escape. Nat Rev
Clin Oncol 2017;14:155-67.
50. Jilaveanu LB, Shuch B, Zito CR, Parisi F, Barr M, Kluger Y, Chen L, Kluger HM. PD-L1 expression in clear cell renal cell carcinoma: an
analysis of nephrectomy and sites of metastases. J Cancer 2014;5:166-72.
51. Mazel M, Jacot W, Pantel K, Bartkowiak K, Topart D, Cayrefourcq L, Rossille D, Maudelonde T, Fest T, Alix-Panabières C. Frequent